Silence Therapeutics reported $118.66M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AstraZeneca USD 27.97B 1.65B Jun/2026
Autolus Therapeutics Ltd USD 368.84M 67.08M Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Novartis USD 27.35B 744M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Silence Therapeutics USD 118.66M 14.97M Dec/2025